NuCana plc (NCNA)
NASDAQ: NCNA · IEX Real-Time Price · USD
2.980
-0.020 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
3.050
+0.070 (2.35%)
Pre-market: Jul 22, 2024, 6:52 AM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $6.69 million as of July 22, 2024. Its market cap has decreased by -84.68% in one year.
Market Cap
6.69M
Enterprise Value
-9.48M
1-Year Change
-84.68%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $6.69M, a decrease of -98.70%. That is a compound annual growth rate of -47.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 6.80M | -56.41% |
Dec 29, 2023 | 15.60M | -54.65% |
Dec 30, 2022 | 34.40M | -72.30% |
Dec 31, 2021 | 124.20M | -21.19% |
Dec 31, 2020 | 157.60M | -19.84% |
Dec 31, 2019 | 196.60M | -57.38% |
Dec 31, 2018 | 461.30M | 43.44% |
Dec 29, 2017 | 321.60M | -37.40% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Notable Labs | 6.97M |
Cadrenal Therapeutics | 6.88M |
Sunshine Biopharma | 6.88M |
Alaunos Therapeutics | 6.76M |
Tenax Therapeutics | 6.70M |
Telesis Bio | 6.69M |
Xenetic Biosciences | 6.41M |
Chromocell Therapeutics | 6.40M |